Information Journal Paper
APA:
CopyVERHAGEN, C.E., DE BOER, T., SMITS, H.H., VERRECK, F.A., WIERENGA, E.A., & KURIMOTO, M.. (2000). RESIDUAL TYPE 1 IMMUNITY IN PATIENTS GENETICALLY DEFICIENT FOR INTERLEUKIN 12 RECEPTOR BETA 1 (IL-12RBETA1): EVIDENCE FOR AN IL-12RBETA1-INDEPENDENT PATHWAY OF IL-12 RESPONSIVENESS IN HUMAN T CELLS. JOURNAL OF EXPERIMENTAL MEDICINE, 192(4), 517-528. SID. https://sid.ir/paper/541453/en
Vancouver:
CopyVERHAGEN C.E., DE BOER T., SMITS H.H., VERRECK F.A., WIERENGA E.A., KURIMOTO M.. RESIDUAL TYPE 1 IMMUNITY IN PATIENTS GENETICALLY DEFICIENT FOR INTERLEUKIN 12 RECEPTOR BETA 1 (IL-12RBETA1): EVIDENCE FOR AN IL-12RBETA1-INDEPENDENT PATHWAY OF IL-12 RESPONSIVENESS IN HUMAN T CELLS. JOURNAL OF EXPERIMENTAL MEDICINE[Internet]. 2000;192(4):517-528. Available from: https://sid.ir/paper/541453/en
IEEE:
CopyC.E. VERHAGEN, T. DE BOER, H.H. SMITS, F.A. VERRECK, E.A. WIERENGA, and M. KURIMOTO, “RESIDUAL TYPE 1 IMMUNITY IN PATIENTS GENETICALLY DEFICIENT FOR INTERLEUKIN 12 RECEPTOR BETA 1 (IL-12RBETA1): EVIDENCE FOR AN IL-12RBETA1-INDEPENDENT PATHWAY OF IL-12 RESPONSIVENESS IN HUMAN T CELLS,” JOURNAL OF EXPERIMENTAL MEDICINE, vol. 192, no. 4, pp. 517–528, 2000, [Online]. Available: https://sid.ir/paper/541453/en